Barrington Research Maintains Outperform on Merit Medical Systems, Maintains $114 Price Target
Barrington Research Maintains Outperform on Merit Medical Systems, Maintains $114 Price Target
Barrington研究維持對merit medical systems的跑贏大盤評級,維持目標股價114美元。
Barrington Research analyst Michael Petusky maintains Merit Medical Systems (NASDAQ:MMSI) with a Outperform and maintains $114 price target.
Barrington Research分析師Michael Petusky認爲梅瑞特醫療系統(NASDAQ:MMSI)是表現良好的,維持目標股價爲114美元。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。